Cargando…

An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China

The Omicron variants spread rapidly worldwide after being initially detected in South Africa in November 2021. It showed increased transmissibility and immune evasion with far more amino acid mutations in the spike (S) protein than the previously circulating variants of concern (VOCs). Notably, on 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meiling, Chen, Zhixiao, Zhou, Jienan, Zhao, Xiaonan, Chen, Yaoyao, Sun, Yanhong, Liu, Zhaosheng, Gu, Wenpeng, Luo, Chunrui, Fu, Xiaoqing, Zhao, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association (CMA) Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613801/
https://www.ncbi.nlm.nih.gov/pubmed/36320663
http://dx.doi.org/10.1016/j.bsheal.2022.10.003
_version_ 1784820053329313792
author Zhang, Meiling
Chen, Zhixiao
Zhou, Jienan
Zhao, Xiaonan
Chen, Yaoyao
Sun, Yanhong
Liu, Zhaosheng
Gu, Wenpeng
Luo, Chunrui
Fu, Xiaoqing
Zhao, Xiang
author_facet Zhang, Meiling
Chen, Zhixiao
Zhou, Jienan
Zhao, Xiaonan
Chen, Yaoyao
Sun, Yanhong
Liu, Zhaosheng
Gu, Wenpeng
Luo, Chunrui
Fu, Xiaoqing
Zhao, Xiang
author_sort Zhang, Meiling
collection PubMed
description The Omicron variants spread rapidly worldwide after being initially detected in South Africa in November 2021. It showed increased transmissibility and immune evasion with far more amino acid mutations in the spike (S) protein than the previously circulating variants of concern (VOCs). Notably, on 15 July 2022, we monitored the first VOC / Omicron subvariant BA.2.75 in China from an imported case. Moreover, nowadays, this subvariant still is predominant in India. It has nine additional mutations in the S protein compared to BA.2, three of which (W152R, G446S, and R493Q reversion) might contribute to higher transmissibility and immune escape. This subvariant could cause wider spread and pose a threat to the global situation. Our timely reporting and continuous genomic analysis are essential to fully elucidate the characteristics of the subvariant BA.2.75 in the future.
format Online
Article
Text
id pubmed-9613801
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Chinese Medical Association (CMA) Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-96138012022-10-28 An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China Zhang, Meiling Chen, Zhixiao Zhou, Jienan Zhao, Xiaonan Chen, Yaoyao Sun, Yanhong Liu, Zhaosheng Gu, Wenpeng Luo, Chunrui Fu, Xiaoqing Zhao, Xiang Biosaf Health Article The Omicron variants spread rapidly worldwide after being initially detected in South Africa in November 2021. It showed increased transmissibility and immune evasion with far more amino acid mutations in the spike (S) protein than the previously circulating variants of concern (VOCs). Notably, on 15 July 2022, we monitored the first VOC / Omicron subvariant BA.2.75 in China from an imported case. Moreover, nowadays, this subvariant still is predominant in India. It has nine additional mutations in the S protein compared to BA.2, three of which (W152R, G446S, and R493Q reversion) might contribute to higher transmissibility and immune escape. This subvariant could cause wider spread and pose a threat to the global situation. Our timely reporting and continuous genomic analysis are essential to fully elucidate the characteristics of the subvariant BA.2.75 in the future. Chinese Medical Association (CMA) Published by Elsevier B.V. 2022-12 2022-10-28 /pmc/articles/PMC9613801/ /pubmed/36320663 http://dx.doi.org/10.1016/j.bsheal.2022.10.003 Text en © 2022 Chinese Medical Association (CMA) Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zhang, Meiling
Chen, Zhixiao
Zhou, Jienan
Zhao, Xiaonan
Chen, Yaoyao
Sun, Yanhong
Liu, Zhaosheng
Gu, Wenpeng
Luo, Chunrui
Fu, Xiaoqing
Zhao, Xiang
An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
title An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
title_full An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
title_fullStr An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
title_full_unstemmed An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
title_short An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China
title_sort imported human case with the sars-cov-2 omicron subvariant ba.2.75 in yunnan province, china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613801/
https://www.ncbi.nlm.nih.gov/pubmed/36320663
http://dx.doi.org/10.1016/j.bsheal.2022.10.003
work_keys_str_mv AT zhangmeiling animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT chenzhixiao animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT zhoujienan animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT zhaoxiaonan animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT chenyaoyao animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT sunyanhong animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT liuzhaosheng animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT guwenpeng animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT luochunrui animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT fuxiaoqing animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT zhaoxiang animportedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT zhangmeiling importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT chenzhixiao importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT zhoujienan importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT zhaoxiaonan importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT chenyaoyao importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT sunyanhong importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT liuzhaosheng importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT guwenpeng importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT luochunrui importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT fuxiaoqing importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina
AT zhaoxiang importedhumancasewiththesarscov2omicronsubvariantba275inyunnanprovincechina